Traex · Trade Info
18-Jun-2026 09:12 PM

Procter & Gamble Health shares rose after strong sales and profit growth

FY 2025 – FY 2026
Buy · 85% Confidence
Symbol
PGHL
Company
Procter & Gamble Health Ltd
Category
Earnings
Source
Official
Sales Growth
16%
Profit Growth
30%
EBITDA Margin
36%
New Product Contribution
Early Single Digit
News Summary
Why This Matters
Fundamental Backdrop (FY 2025 – FY 2026)
Metric Value
Sales Growth Percentage16%
Profit After Tax Growth30%
EBITDA Margin36%
New Product Launches ContributionEarly Single Digit Points
Analyst's View
Buy
Confidence 85%
Conviction Level 85%
Strong sales and profit growth combined with new product success makes this a positive investment.

Key Positives

  • Sales grew by 16% while profits grew by 30% last year.
  • New products like iron gummies are performing very well on online platforms.
  • The company has successfully expanded its pharmacy distribution network.
  • Strong focus on productivity helps maintain healthy profit margins.

Key Risks

  • Regulations on drug pricing may limit future price increases.
  • New product launches take time to build up full market acceptance.
  • Competition in the vitamin and supplement space remains high.
HorizonLong Term
Confidence LevelHigh
Suggested position size: Maintain or Increase
⚠️
Disclaimer This analysis is for informational purposes only and does not constitute financial advice. Do your own research and consult a qualified financial professional before making any investment decisions.